These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3345522

  • 1. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta.
    Ohno Y, Spriggs D, Matsukage A, Ohno T, Kufe D.
    Cancer Res; 1988 Mar 15; 48(6):1494-8. PubMed ID: 3345522
    [Abstract] [Full Text] [Related]

  • 2. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.
    Townsend AJ, Cheng YC.
    Mol Pharmacol; 1987 Sep 15; 32(3):330-9. PubMed ID: 2444869
    [Abstract] [Full Text] [Related]

  • 3. Sequence-specific inhibition of DNA strand elongation by incorporation of 9-beta-D-arabinofuranosyladenine.
    Ohno Y, Spriggs D, Matsukage A, Ohno T, Kufe D.
    Cancer Res; 1989 Apr 15; 49(8):2077-81. PubMed ID: 2467740
    [Abstract] [Full Text] [Related]

  • 4. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
    Kufe DW, Munroe D, Herrick D, Egan E, Spriggs D.
    Mol Pharmacol; 1984 Jul 15; 26(1):128-34. PubMed ID: 6431261
    [Abstract] [Full Text] [Related]

  • 5. Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.
    Gandhi V, Huang P, Chapman AJ, Chen F, Plunkett W.
    Clin Cancer Res; 1997 Aug 15; 3(8):1347-55. PubMed ID: 9815818
    [Abstract] [Full Text] [Related]

  • 6. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D, Herrick D, Crumpacker C, Schnipper L.
    Cancer Res; 1984 Jan 15; 44(1):69-73. PubMed ID: 6317173
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
    Grem JL, Allegra CJ.
    Cancer Res; 1990 Nov 15; 50(22):7279-84. PubMed ID: 1699659
    [Abstract] [Full Text] [Related]

  • 8. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD, Chen SR, Cuddy DP.
    Cancer Res; 1990 May 01; 50(9):2658-66. PubMed ID: 2328491
    [Abstract] [Full Text] [Related]

  • 9. 1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells.
    Myers-Robfogel MW, Spataro AC.
    Cancer Res; 1980 Jun 01; 40(6):1940-3. PubMed ID: 7371029
    [Abstract] [Full Text] [Related]

  • 10. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
    Liliemark JO, Plunkett W.
    Cancer Res; 1986 Mar 01; 46(3):1079-83. PubMed ID: 3484676
    [Abstract] [Full Text] [Related]

  • 11. Ara-C differentially affects multiprotein forms of human cell DNA polymerase.
    Wills PW, Hickey R, Malkas L.
    Cancer Chemother Pharmacol; 2000 Mar 01; 46(3):193-203. PubMed ID: 11021736
    [Abstract] [Full Text] [Related]

  • 12. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Danhauser LL, Rustum YM.
    Cancer Res; 1985 May 01; 45(5):2002-7. PubMed ID: 3986756
    [Abstract] [Full Text] [Related]

  • 13. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ, Kufe DW.
    Cancer Res; 1982 Oct 01; 42(10):4050-3. PubMed ID: 6809309
    [Abstract] [Full Text] [Related]

  • 14. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD.
    Oncol Res; 1994 Oct 01; 6(2):87-99. PubMed ID: 7949469
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
    Kufe DW, Weichselbaum R, Egan EM, Dahlberg W, Fram RJ.
    Mol Pharmacol; 1984 Mar 01; 25(2):322-6. PubMed ID: 6700578
    [Abstract] [Full Text] [Related]

  • 17. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.
    Seymour JF, Huang P, Plunkett W, Gandhi V.
    Clin Cancer Res; 1996 Apr 01; 2(4):653-8. PubMed ID: 9816215
    [Abstract] [Full Text] [Related]

  • 18. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO, Plunkett W, Dixon DO.
    Cancer Res; 1985 Nov 01; 45(11 Pt 2):5952-7. PubMed ID: 4053067
    [Abstract] [Full Text] [Related]

  • 19. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM, Kuiper CM, Voorn DA, Comijn EM, Myhren F, Sandvold ML, Hendriks HR, Peters GJ.
    Biochem Pharmacol; 2004 Feb 01; 67(3):503-11. PubMed ID: 15037202
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside.
    Tanaka M, Kimura K, Yoshida S.
    Jpn J Cancer Res; 1985 Aug 01; 76(8):729-35. PubMed ID: 3930450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.